Angiotensin A peptide
Not For Human Use, Lab Use Only.
Cat.#: 310420
Special Price 161.90 USD
-
Product Name
Angiotensin A peptide
-
Documents
Batch to batch variation of the purity
-
Sequence Shortening
ARVYIHPF
-
Sequence
H-Ala-Arg-Val-Tyr-Ile-His-Pro-Phe-OH
-
Length (aa)
8
-
Peptide Purity (HPLC)
96.2%
-
Molecular Formula
C49H71N13O10
-
Molecular Weight
1002.18
-
CAS No.
51833-76-2
-
Source
Synthetic
-
Form
Powder
-
Description
Angiotensin A is a novel octapeptide of the renin–angiotensin system (RAS) that was first identified in human plasma. Its amino acid sequence is Ala-Arg-Val-Tyr-Ile-His-Pro-Phe, differing from angiotensin II by the substitution of Ala for Asp at the first position (Des[Asp1]-[Ala1]-Ang II). Angiotensin A is synthesized by enzymatic decarboxylation of the Asp1 residue of the angiotensin II sequence.
In isolated perfused rat kidney, angiotensin A causes AT1 receptor-dependent vasoconstriction, and it elicits pressor and renal vasoconstrictor responses in both normotensive and hypertensive rats that are abolished by AT1 receptor antagonists. In the heart, angiotensin A reduces coronary flow, cardiac contraction velocity and heart rate, with these effects only partially blocked by AT1 receptor antagonism, suggesting the involvement of additional receptor pathways. Unlike angiotensin II, angiotensin A does not significantly increase reperfusion arrhythmias and does not alter the amplitude of electrically induced intracellular calcium transients in isolated ventricular cardiomyocytes under baseline or ischemic stress conditions.
-
Storage Guidelines
Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
-
References
- Coutinho DC, Foureaux G, Rodrigues KD, Salles RL, Moraes PL, Murça TM, De Maria ML, Gomes ER, Santos RA, Guatimosim S, Ferreira AJ. Cardiovascular effects of angiotensin A: a novel peptide of the renin-angiotensin system. J Renin Angiotensin Aldosterone Syst. 2014 Dec;15(4):480-6. doi: 10.1177/1470320312474856. Epub 2013 Feb 5. PMID: 23386282.
-
About TFA salt
Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.
Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.
Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.
In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.
- Molar Concentration Calculator
- Dilution Calculator
- Percent Concentration Calculator
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Related Products / Services
• Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.
• Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.
• Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"